GHK-Cu

GHK-Cu (glycyl-L-histidyl-L-lysine:copper(II)) is a synthetic copper-binding tripeptide examined in preclinical laboratory models. Published studies have investigated its interactions with gene expression constructs, extracellular matrix components, and cellular signaling pathways in vitro. Pepticore supplies this compound exclusively as a laboratory reference material. No biological outcomes or suitability for human use is implied or established.

GHK was first identified in the 1970s during studies of plasma protein interactions. Subsequent research examined the structural properties of GHK complexed with copper in laboratory assay models. It has since been investigated across multiple in vitro research formats examining peptide-copper binding interactions and extracellular matrix signaling constructs.

Peer-reviewed literature has examined GHK-Cu's binding characteristics across the following in vitro assay categories:

• Extracellular matrix assays: structural protein and collagen interaction studies
• Gene expression constructs: transcription factor interaction modeling
• Vascular cell culture models: endothelial receptor interaction profiling
• Epithelial cell culture models: barrier function and structural assay research

All findings referenced here are sourced from third-party peer-reviewed publications. Pepticore makes no independent claims regarding biological activity, efficacy, or outcomes for this compound.

Published literature examining GHK-Cu's structural binding properties is accessible via PubMed (CAS: 49557-75-7).